BioCentury | Dec 21, 2009
Company News

Viral Genetics, University of Colorado deal

Viral Genetics exercised its option for an exclusive, worldwide license to develop cancer therapies using the university's metabolic disruption technology. The technology blocks tumor cells' ability to generate energy from glucose or fatty acids. Financial...
BioCentury | Dec 14, 2009
Company News

Viral Genetics, University of Colorado deal

Viral Genetics now has rights to the university's IP to target peptides to treat all immune-related disorders. Previously, under a 2008 deal, Viral Genetics' use of the IP was limited to the diagnosis and treatment...
BioCentury | Aug 17, 2009
Company News

Viral Genetics, University of Colorado, University of Vermont cancer news

Viral Genetics created a wholly owned subsidiary called MetaCytoLytics Inc. to develop technology from the universities which blocks a tumor cell's ability to generate energy from glucose or fatty acids. The company is completing negotiations...
Items per page:
1 - 3 of 3
BioCentury | Dec 21, 2009
Company News

Viral Genetics, University of Colorado deal

Viral Genetics exercised its option for an exclusive, worldwide license to develop cancer therapies using the university's metabolic disruption technology. The technology blocks tumor cells' ability to generate energy from glucose or fatty acids. Financial...
BioCentury | Dec 14, 2009
Company News

Viral Genetics, University of Colorado deal

Viral Genetics now has rights to the university's IP to target peptides to treat all immune-related disorders. Previously, under a 2008 deal, Viral Genetics' use of the IP was limited to the diagnosis and treatment...
BioCentury | Aug 17, 2009
Company News

Viral Genetics, University of Colorado, University of Vermont cancer news

Viral Genetics created a wholly owned subsidiary called MetaCytoLytics Inc. to develop technology from the universities which blocks a tumor cell's ability to generate energy from glucose or fatty acids. The company is completing negotiations...
Items per page:
1 - 3 of 3